Cargando…
METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m(6)A-dependent manner
BACKGROUND: The molecular mechanisms driving hepatocellular carcinoma (HCC) remain largely unclear. As one of the major epitranscriptomic modifications, N(6)-methyladenosine (m(6)A) plays key roles in HCC. The aim of this study was to investigate the expression, roles, and mechanisms of action of th...
Autores principales: | Dai, Yun-zhang, Liu, Yong-da, Li, Jie, Chen, Mei-ting, Huang, Mei, Wang, Fang, Yang, Qing-song, Yuan, Ji-hang, Sun, Shu-han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123709/ https://www.ncbi.nlm.nih.gov/pubmed/35596159 http://dx.doi.org/10.1186/s11658-022-00342-8 |
Ejemplares similares
-
CircMETTL3, upregulated in a m6A-dependent manner, promotes breast cancer progression
por: Li, Zhi, et al.
Publicado: (2021) -
METTL16-mediated translation of CIDEA promotes non-alcoholic fatty liver disease progression via m6A-dependent manner
por: Tang, Jinhong, et al.
Publicado: (2022) -
Rab11 in Disease Progression
por: Bhuin, Tanmay, et al.
Publicado: (2015) -
The Distinct Function and Localization of METTL3/METTL14 and METTL16 Enzymes in Cardiomyocytes
por: Arcidiacono, Orazio Angelo, et al.
Publicado: (2020) -
Analysis of METTL3 and METTL14 in hepatocellular carcinoma
por: Liu, Xiangxiang, et al.
Publicado: (2020)